Press Releases

Feb 10, 2022
Twist Bioscience to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
Feb 09, 2022
Twist Bioscience Announces Proposed Public Offering of Common Stock
Feb 08, 2022
C2i Genomics Partners with Twist Bioscience to Launch Reference Materials for Whole-Genome Cancer Detection
Feb 07, 2022
Twist Bioscience and Eleven Therapeutics Create Replicon for Development of Antiviral Tools
Feb 04, 2022
Twist Bioscience Reports First Quarter 2022 Financial Results
Feb 01, 2022
Abcam Collaborates With Twist Bioscience to Enhance Antibody Discovery for Diagnostic and Research Applications
Jan 31, 2022
Twist Bioscience Releases Inaugural ESG Report Highlighting Achievements and Initiatives in Diversity and Sustainability
Jan 25, 2022
Twist Bioscience Signs Collaboration with Artisan Bio to Engineer Next Generation Cell Therapeutics
Jan 20, 2022
Twist Bioscience to Report Fiscal 2022 First Quarter Financial Results on Friday, February 4, 2022
Jan 10, 2022
Twist Bioscience’s Comprehensive DNA Synthesis Capabilities Expanded as Industry-Leading Enzymatic Synthesis Process Unveiled at Annual J.P. Morgan Healthcare Conference